Jinsong Ni is the founder of Cloudbreak Therapeutics. Latest round: Series C. Backed by CCB International, CDH Investments, Grand Pharmaceutical.
Jinsong Ni is the Founder and Chief Executive Officer of Cloudbreak Pharma, a clinical-stage ophthalmic drug company. Cloudbreak Pharma utilizes a proprietary Multi-Kinase Inhibitors (MKI) technology and has lead assets in mid-Phase 3 clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library